Navigating the New Frontier: The First Abridged Complaint under the 2024 ABPI Code
In the ever-evolving landscape of pharmaceutical marketing, the industry faces a delicate balance between informing the public and adhering to strict regulations. This challenge was thrust into the spotlight with the recent case of CSL Seqirus and the alleged promotion of their prescription-only Flucelvax Influenza vaccine on the social media platform LinkedIn.
- Millions of new solar system objects to be found...
on June, 2025 at 1:34 amAstronomers have revealed new research showing that millions of new solar system objects are likely to be detected by a brand-new facility, which is expected to come online later this year.
- Collaboration can unlock Australia's energy...on June, 2025 at 9:29 pm
New research demonstrates that with collaboration between stakeholders, Australia can fully decarbonize its domestic and energy export economies by 2060 -- a feat requiring $6.2 trillion USD and around 110,000 square kilomters of land -- while avoiding harm to important areas for biodiversity […]
- Guardrails, education urged to protect adolescent...on June, 2025 at 6:12 pm
The effects of artificial intelligence on adolescents are nuanced and complex, according to a new report that calls on developers to prioritize features that protect young people from exploitation, manipulation and the erosion of real-world relationships.
- Molecular link between air pollution and...on June, 2025 at 6:12 pm
A new study found exposure to specific tiny particles in air pollution during pregnancy are associated with increased risk of various negative birth outcomes.
- Atmospheric chemistry keeps pollutants in the airon June, 2025 at 3:50 pm
A new study details processes that keep pollutants aloft despite a drop in emissions.
11 年后，波士顿动力公司（Boston Dynamics）与其仿人机器人 ATLAS HD 说再见了。这家机器人公司表示，现在是 ATLAS 退休 "休息放松 "的时候了，新的全电动 ATLAS 将接替它的工作。分享这段视频是为了纪念 ATLAS HD 的伟大时刻和那些不那么伟大的时刻。
标题横幅：AZT 是齐多夫定的研发名称，是第一种用于治疗艾滋病的药物。它被用于大剂量和单一疗法，造成了可怕的副作用和艾滋病病毒的抗药性。在随后 30 年的临床试验中，开发出了单片、每日一次、副作用有限的艾滋病治疗方案。现在，人们可以服用一种名为特鲁瓦达（Truvada）的双药组合来预防感染艾滋病毒的风险（如 DarkDrug 徽标所示）。
